You have 9 free searches left this month | to do more

alemtuzumab

Alemtuzumab is a drug used to treat Leukemia, Lymphoma, Sickle Cell Disease, and other conditions. Alemtuzumab is being actively studied in 27 studies and prior, has been studied in 71.

Top SponsorsTop SitesTop Investigators
M.D. Anderson Cancer CenterBeth Israel Deaconess Medical CenterPaul Szabolcs
National Cancer Institute (NCI)Dana-Farber Cancer InstituteBrenda Sandmaier
National Institute of Allergy and Infectious Diseases (NIAID)Mayo ClinicDamiano Rondelli, MD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
G
Completed
  • T-cell-prolymphocytic Leukemia
  • Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab
  • Alemtuzumab
  • Cologne, Germany
    University Hospital Cologne
2021-12-16
Dec 16, 2021
M
Active, not recruiting
  • Leukemia
  • Alemtuzumab
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2022-02-02
Feb 2, 2022
U
Completed
  • Multiple Sclerosis, Relapsing-Remitting
  • Alemtuzumab
  • Münster, Germany
    Universitätsklinikum Münster, Klinik für Allgemeine Neurologie
2021-10-25
Oct 25, 2021
U
Terminated
  • Relapsing-Remitting Multiple Sclerosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Hamburg, Germany
  • +1 more
2022-03-01
Mar 1, 2022
H
Recruiting
  • Multiple Sclerosis
  • Cyclophosphamide and ATG
  • Alemtuzumab
  • Copenhagen, Denmark
  • +7 more
2022-03-18
Mar 18, 2022
M
Recruiting
  • Recurrent T-Cell Prolymphocytic Leukemia
  • T-Cell Prolymphocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
2021-06-11
Jun 11, 2021
U
Completed
  • Multiple Sclerosis (MS)
  • Alemtuzumab
  • Dallas, Texas
  • +1 more
2022-01-24
Jan 24, 2022
A
Completed
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Innsbruck, Tirol, Austria
  • +6 more
2022-02-15
Feb 15, 2022
A
Completed
  • Hemophagocytic Lymphohistiocytosis (HLH)
  • Alemtuzumab
  • +2 more
  • Paris, France
    Hôpital Necker-Enfants Malades
2021-04-13
Apr 13, 2021
H
Active, not recruiting
  • Sickle Cell Disease
  • Alemtuzumab
  • +3 more
  • Hackensack, New Jersey
    Hackensack University Medical Center
2022-02-04
Feb 4, 2022
U
Terminated
  • Acute Lymphoblastic Leukemia
  • La Jolla, California
  • +2 more
2020-07-29
Jul 29, 2020
Q
Terminated
  • Multiple Sclerosis
  • Alemtuzumab
  • London, England, United Kingdom
    Queen Mary University of London
2022-02-09
Feb 9, 2022
U
Completed
  • Renal Transplantation
  • Alemtuzumab
  • +5 more
  • San Francisco, California
  • +7 more
2021-07-08
Jul 8, 2021
K
Recruiting
  • Sickle Cell Disease
  • Alemtuzumab
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
2021-03-22
Mar 22, 2021
W
Terminated
  • Sickle Cell Disease
  • Alemtuzumab
  • +6 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-01-28
Jan 28, 2022
N
Suspended
  • Chronic Granulomatous Disease
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
C
Active, not recruiting
  • Sickle Cell Disease
  • Beta Thalassemia
  • New York, New York
    Morgan Stanley Children's Hospital, New York-Presbyterian, Colum
2021-08-12
Aug 12, 2021
C
Completed
  • Allogeneic Hematopoietic Cell Transplantation
  • Alemtuzumab
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
2019-10-03
Oct 3, 2019
C
Terminated
  • Epidermolysis Bullosa
  • Aurora, Colorado
  • +2 more
2021-08-13
Aug 13, 2021
U
Recruiting
  • Diabetes Mellitus, Type 1
  • Edmonton, Alberta, Canada
    University of Alberta
2022-04-01
Apr 1, 2022
U
Recruiting
  • Sickle Cell Disease
  • Allogeneic Non-Myeloablative Stem Cell Transplantation
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
2022-02-16
Feb 16, 2022
M
Recruiting
  • Dyskeratosis Congenita
  • Aplastic Anemia
  • Alemtuzumab
  • +5 more
  • Minneapolis, Minnesota
    University of Minnesota Medical Center, Fairview
2022-01-20
Jan 20, 2022
U
Recruiting
  • Sickle Cell Disease
  • +3 more
  • Alemtuzumab
  • +2 more
  • Calgary, Alberta, Canada
    Alberta Children's Hospital
2021-05-25
May 25, 2021
N
Active, not recruiting
  • Sickle Cell Anemia
  • PBSC Transplant
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-03-04
Mar 4, 2021
U
Completed
  • Evidence of Liver Transplantation
  • +2 more
  • Alemtuzumab
  • (no location specified)
2019-07-01
Jul 1, 2019